BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND KMT2C, ENSG00000055609, MLL3, 58508
15 results:

  • 1. Osteosarcoma's genetic landscape painted by genes' mutations.
    Urban W; KrzystaƄska D; Piekarz M; Nazar J; Jankowska A
    Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts.
    Xu H; Zheng H; Zhang Q; Song H; Wang Q; Xiao J; Dong Y; Shen Z; Wang S; Wu S; Wei Y; Lu W; Zhu Y; Niu X
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e48-e59. PubMed ID: 35781406
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
    Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
    Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
    Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
    J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recurrent secondary genomic alterations in desmoplastic small round cell tumors.
    Chow WA; Yee JK; Tsark W; Wu X; Qin H; Guan M; Ross JS; Ali SM; Millis SZ
    BMC Med Genet; 2020 May; 21(1):101. PubMed ID: 32393201
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. kmt2c modulates migration and invasion processes in osteosarcoma cell lines.
    Chiappetta C; Carletti R; Della Rocca C; Di Cristofano C
    Pathol Res Pract; 2019 Oct; 215(10):152534. PubMed ID: 31337554
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic sarcomas Identified by Targeted Next-generation Sequencing.
    Zheng B; Qu Y; Wang J; Shi Y; Yan W
    Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study.
    Stevens TM; Morlote D; Swensen J; Ellis M; Harada S; Spencer S; Prieto-Granada CN; Folpe AL; Gatalica Z
    Head Neck Pathol; 2019 Jun; 13(2):162-168. PubMed ID: 29736783
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
    Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
    Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma.
    Weyand AC; Mody RJ; Rabah RM; Opipari VP
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675691
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.
    Chmielecki J; Bailey M; He J; Elvin J; Vergilio JA; Ramkissoon S; Suh J; Frampton GM; Sun JX; Morley S; Spritz D; Ali S; Gay L; Erlich RL; Ross JS; Buxhaku J; Davies H; Faso V; Germain A; Glanville B; Miller VA; Stephens PJ; Janeway KA; Maris JM; Meshinchi S; Pugh TJ; Shern JF; Lipson D
    Cancer Res; 2017 Jan; 77(2):509-519. PubMed ID: 28069802
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
    Hembree TN; Teer JK; Hakam A; Chiappori AA
    Cancer Control; 2016 Jan; 23(1):61-6. PubMed ID: 27009459
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Uterine adenosarcomas are mesenchymal neoplasms.
    Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
    J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.
    Jones S; Stransky N; McCord CL; Cerami E; Lagowski J; Kelly D; Angiuoli SV; Sausen M; Kann L; Shukla M; Makar R; Wood LD; Diaz LA; Lengauer C; Velculescu VE
    Nat Commun; 2014 Sep; 5():5006. PubMed ID: 25233892
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity.
    Lohberger B; Stuendl N; Wolf E; Liegl-Atzwanger B; Leithner A; Rinner B
    BMC Cancer; 2013 Dec; 13():563. PubMed ID: 24289252
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.